Microlife Cradle VSA (BP 3GP1-1L)
There appears to be no peer-reviewed clinical validation information available on the technology used in the Microlife Cradle VSA (BP 3GP1-1L) to measure blood pressure.
| Accuracy Assessment | Recommendation | Basis | ||
|---|---|---|---|---|
| Medaval | Not recommended | This device has not been clinically validated. | ||
| ESH (Europe) | Professional use for pregnancy | A validation, without a reference, which Medaval is unable to identify. | ||
Nathan HL, Duhig K, Vousden N, Lawley E, Seed PT, Sandall J, Bellad MB, Brown AC, Chappell LC, Goudar SS, Gidiri MF, Shennan AH; CRADLE-3 Trial Collaboration Group. Evaluation of a novel device for the management of high blood pressure and shock in pregnancy in low-resource settings: study protocol for a stepped-wedge cluster-randomised controlled trial (CRADLE-3 trial). Trials. 2018 Mar 27;19(1):206. doi: 10.1186/s13063-018-2581-z. PMID: 29587875. Available from: trialsjournal.biomedcentral.com.
The CRADLE-3 Trial will demonstrate the potential impact of the CRADLE intervention, following protocol evaluation in a feasibility study, with subsequent optimisation, on reducing maternal mortality and morbidity in low-resource settings.
